These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11819752)

  • 21. Is rhodamine 123 an appropriate fluorescent probe to assess P-glycoprotein mediated multidrug resistance in vinblastine-resistant CHO cells?
    Pétriz J; O'Connor JE; Carmona M; García-López J
    Anal Cell Pathol; 1997; 14(3):129-40. PubMed ID: 9354229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic investigation of taxol and taxotere resistance and invasiveness in a squamous lung carcinoma cell line.
    Murphy L; Henry M; Meleady P; Clynes M; Keenan J
    Biochim Biophys Acta; 2008 Sep; 1784(9):1184-91. PubMed ID: 18503785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of a new anticancer drug, docetaxel (RP56976), on human leukemia cell lines].
    Murata K; Sato T; Kanamaru R
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):307-13. PubMed ID: 7906506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical pharmacology of docetaxel.
    Bissery MC
    Eur J Cancer; 1995; 31A Suppl 4():S1-6. PubMed ID: 7577097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The scientific rationale for developing taxoids.
    Aapro M
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-proliferative activity of a new class of taxanes (14beta-hydroxy-10-deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cells.
    Distefano M; Scambia G; Ferlini C; Gaggini C; De Vincenzo R; Riva A; Bombardelli E; Ojima I; Fattorossi A; Panici PB; Mancuso S
    Int J Cancer; 1997 Sep; 72(5):844-50. PubMed ID: 9311603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docetaxel in breast cancer and a rationale for combination therapy.
    Hortobágyi G
    Oncology (Williston Park); 1997 Jun; 11(6 Suppl 6):11-5. PubMed ID: 9213321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.
    Avramis IA; Kwock R; Avramis VI
    Anticancer Res; 2001; 21(4A):2281-6. PubMed ID: 11724283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syntheses and biological activity of C-3'-difluoromethyl-taxoids.
    Ojima I; Lin S; Slater JC; Wang T; Pera P; Bernacki RJ; Ferlini C; Scambia G
    Bioorg Med Chem; 2000 Jul; 8(7):1619-28. PubMed ID: 10976509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction of gadd153 gene into gastric cancer cells can modulate sensitivity to anticancer agents in association with apoptosis.
    Kim R; Ohi Y; Inoue H; Aogi K; Toge T
    Anticancer Res; 1999; 19(3A):1779-83. PubMed ID: 10470115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oligonucleotide modulation of multidrug resistance.
    Bouffard DY; Ohkawa T; Kijima H; Irie A; Suzuki T; Curcio LD; Holm PS; Sassani A; Scanlon KJ
    Eur J Cancer; 1996 Jun; 32A(6):1010-8. PubMed ID: 8763342
    [No Abstract]   [Full Text] [Related]  

  • 32. MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells.
    Chen GK; Durán GE; Mangili A; Beketic-Oreskovic L; Sikic BI
    Br J Cancer; 2000 Oct; 83(7):892-8. PubMed ID: 10970691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness.
    Liang Y; Meleady P; Cleary I; McDonnell S; Connolly L; Clynes M
    Eur J Cancer; 2001 May; 37(8):1041-52. PubMed ID: 11334731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular diagnosis of multidrug resistance.
    Herzog CE; Bates SE
    Cancer Treat Res; 1994; 73():129-47. PubMed ID: 7710903
    [No Abstract]   [Full Text] [Related]  

  • 35. Overcoming multidrug resistance in taxane chemotherapy.
    Geney R; Ungureanu lM; Li D; Ojima I
    Clin Chem Lab Med; 2002 Sep; 40(9):918-25. PubMed ID: 12435109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Taxane analogues: distinguishing royal robes from the "Emperor's New Clothes".
    Rowinsky EK
    Clin Cancer Res; 2002 Sep; 8(9):2759-63. PubMed ID: 12231513
    [No Abstract]   [Full Text] [Related]  

  • 37. Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers.
    Wils P; Phung-Ba V; Warnery A; Lechardeur D; Raeissi S; Hidalgo IJ; Scherman D
    Biochem Pharmacol; 1994 Oct; 48(7):1528-30. PubMed ID: 7945455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth inhibitory effects of paclitaxel on human epithelioid sarcoma in vitro: heterogeneity of response and the multidrug resistance phenotype.
    Reinecke P; Knopf C; Schmitz M; Schneider EM; Gabbert HE; Gerharz CD
    Cancer; 2000 Apr; 88(7):1614-22. PubMed ID: 10738220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syntheses and structure-activity relationships of taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III.
    Ojima I; Slater JC; Kuduk SD; Takeuchi CS; Gimi RH; Sun CM; Park YH; Pera P; Veith JM; Bernacki RJ
    J Med Chem; 1997 Jan; 40(3):267-78. PubMed ID: 9022793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Taxoids: structural and experimental properties].
    Lavelle F; Combeau C; Commerçon A
    Bull Cancer; 1995 Apr; 82(4):249-64. PubMed ID: 10846536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.